MedTrace Logo

Ibuprofen and Paracetamol Pharmacokinetic Study

NCT02452450 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2015-05-27

No results posted yet for this study

Summary

The purpose of this study was to determine rates of absorption of Ibuprofen and Paracetamol formulations.

Conditions

  • Healthy Volunteer Study

Interventions

DRUG

Ibuprofen Acid

DRUG

Ibuprofen Lysine

DRUG

Ibuprofen Sodium

DRUG

Ibuprofen Liquid Capsules

DRUG

Paracetamol

Sponsors & Collaborators

  • Simbec Research

    collaborator INDUSTRY

  • Reckitt Benckiser Healthcare (UK) Limited

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2014-10-31
Completion
2014-10-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02452450 on ClinicalTrials.gov